![Evaluation of effectiveness and safety of acyclovir 1gm twice a day for treatment of recurrent genital herpes Kaushal Verma, M Sunane, Somesh Gupta All. - ppt download Evaluation of effectiveness and safety of acyclovir 1gm twice a day for treatment of recurrent genital herpes Kaushal Verma, M Sunane, Somesh Gupta All. - ppt download](https://images.slideplayer.com/42/11475729/slides/slide_7.jpg)
Evaluation of effectiveness and safety of acyclovir 1gm twice a day for treatment of recurrent genital herpes Kaushal Verma, M Sunane, Somesh Gupta All. - ppt download
![Table 1 from Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. | Semantic Scholar Table 1 from Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8b80fdb62e5d1cdfe535f83c7d0d827c0115441e/2-Table1-1.png)
Table 1 from Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. | Semantic Scholar
![Buy Valtrex (valacyclovir) Online Without Prescription | Anberry Nursing and Rehabilitation Center | California, US Buy Valtrex (valacyclovir) Online Without Prescription | Anberry Nursing and Rehabilitation Center | California, US](https://www.anberryhospital.com/images/valtrex-1.png)
Buy Valtrex (valacyclovir) Online Without Prescription | Anberry Nursing and Rehabilitation Center | California, US
![IJMS | Free Full-Text | 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs? IJMS | Free Full-Text | 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?](https://www.mdpi.com/ijms/ijms-23-03431/article_deploy/html/images/ijms-23-03431-g001.png)
IJMS | Free Full-Text | 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?
![Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials - The Lancet](https://www.thelancet.com/cms/attachment/a6e04134-5021-4c69-8936-add20f5e935d/gr1.gif)